New drug shows synergistic effect with antifungals in killing drug-resistant fungi

FHS
July 10, 2023
11:37 pm

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

The Biggest Psychedelic News This Week: November 20th-24th

Massachusetts is pushing for legalization on the 2024 ballot, a move that could change the game. A recent study has found intriguing parallels between psychedelic

November 24, 2023

ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction – Pharmaceutical Technology

At the ESC Congress, Dr. Milton Packer highlighted recent research into beta blocker treatment for myocardial infarction. Credit: luchschenF via Shutterstock. A shift in the

September 3, 2024

Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma – Pharmaceutical Technology

Tecelra is genetically engineered to target melanoma-associated antigen A4 (MAGE-A4). Image: Shutterstock/Christoph Burgstedt Oxford-based cell therapy company Adaptimmune Therapeutics has received accelerated approval from the

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.